Pharmacodynamic biomarker - or psychotherapeutic process? Comment on “The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression”
No abstract is available for this record.
Bibliographic context
Topics and keywords
psilocybin DepressionChronic PainPharmacologyBiomarkersTreatment-Resistant DepressionToxicity Other PsilocybinMedicineHallucinogenPharmacodynamicsBiomarkerPharmacologyPsychotherapistPsychiatryDepression (economics)MEDLINEPsychologyLysergic acid diethylamidePsychedelics and Drug StudiesPain Management and Placebo EffectForensic Toxicology and Drug Analysis
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
No close related records were found yet.